Sheila AM Rauch

Treatment of active duty military with PTSD in primary care: A follow-up report.

Physical Activity Moderates the Association Between Pain and PTSD in Treatment-Seeking Veterans.

Changes in Salivary Cortisol During Psychotherapy for Posttraumatic Stress Disorder: A Pilot Study in 30 Veterans.

Temporal Sequencing of Change in Posttraumatic Cognitions and PTSD Symptom Reduction During Prolonged Exposure Therapy.

Integrating biological treatment mechanisms into randomized clinical trials: Design of PROGrESS (PROlonGed ExpoSure and Sertraline Trial).

Design of a randomized controlled trial examining the efficacy and biological mechanisms of web-prolonged exposure and present-centered therapy for PTSD among active-duty military personnel and veterans.

In session extinction and outcome in Virtual Reality Exposure Therapy for PTSD.

Cortisol awakening response in PTSD treatment: Predictor or mechanism of change.

Neuroendocrine biomarkers of prolonged exposure treatment response in military-related PTSD.

Corrigendum to "Neuroendocrine biomarkers of prolonged exposure treatment response in military-related PTSD" [Psychoneuroendocrinology (2020) Article 104749].

Predictors of Response to Prolonged Exposure, Sertraline, and Their Combination for the Treatment of Military PTSD.

Reductions in guilt cognitions following prolonged exposure and/or sertraline predict subsequent improvements in PTSD and depression.

STRONG STAR and the Consortium to Alleviate PTSD: Shaping the future of combat PTSD and related conditions in military and veteran populations.

Long-term effectiveness of a prolonged exposure-based intensive outpatient program for veterans with posttraumatic stress disorder.

Improving function through primary care treatment of PTSD: The IMPACT study protocol.

Frequency and correlates of suicidal ideation and behaviors in treatment-seeking Post-9/11 Veterans.